June 20, 2022— Members of the U.S. House of Representatives from both political parties went to the House floor recently to deliver a historic series of speeches honoring the upcoming 30th anniversary of the 340B drug pricing program and urging their colleagues to defend the program against unlawful attacks by drug companies. The lawmakers’ unified message was that 340B is … [Read more...]
GlaxoSmithKline Policy Threatens Asthma Care
Feb. 16, 2022– Just days after President Biden spoke out in support of the 340B drug pricing program, drug giant GlaxoSmithKline (GSK) announced it will begin withholding 340B discounts starting in April for most safety-net hospitals. That action will bring the number of drug companies violating the 340B law to 14. In 2021, GSK reported more than $45 billion in global sales, … [Read more...]
Bipartisan Congressional Calls to Protect 340B Intensify
Aug. 4, 2021– A pair of lawmakers is working to advance the latest example of bipartisan, pro-340B legislation in Congress. Reps. Abigail Spanberger (D-Va.) and David McKinley (R-W.V.) recently introduced the Preserving Rules Ordered for The Entities Covered Through 340B Act, also known as the PROTECT 340B Act, and are gathering cosponsors from both sides of the political … [Read more...]